The FDA issued a final guidance that describes the agency’s current recommendations to sponsors of master protocols evaluating drugs for the treatment or prevention of COVID-19.
Read more: FDA In Brief: FDA Provides Guidance on Master Protocols for Evaluating Prevention, Treatment Options for COVID-19